| Literature DB >> 34950698 |
José A Hernández-Hermoso1,2, José Moranas-Barrero3, Ester García-Oltra1,2, Fernando Collado-Saenz1,2, Sylvia López-Marne3.
Abstract
Objective: The aim was to report 4 patients with intra-articular knee synovial haemangioma (KSH) and to perform a systematic review to describe the patient characteristics, patterns of tumor location, clinical presentation, usefulness of imaging examinations, pros and cons of arthroscopic vs. open resection, and follow-up in the literature. Design: From 1996 to 2016, four patients with KSH were retrospectively reviewed. A literature search was conducted in PubMed from 2000/01 to 2020/06 using the search terms "synovial haemangioma" and "knee." Fifty full-text articles that included a total of 92 patients were included for further discussion.Entities:
Keywords: arthroscopy; haemangioma; knee; magnetic resonance; synovial
Year: 2021 PMID: 34950698 PMCID: PMC8688361 DOI: 10.3389/fsurg.2021.792380
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Clinical case demographics, tumor location, clinic, image examinations, treatment, histology, and follow-up.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | 20 | M | R | SP-Q | No | P-H | Nr | 5 y | XR-Sc-MRI | Yes | OS | AV | 4 y | Yes |
| Case 2 | 22 | M | R | SP-Q | No | P | Nr | 6 y | XR-MRIN-MRI | Yes | AN-OS | AV | 5 y | No |
| Case 3 | 31 | M | R | SP | No | P-PA-S-T | Nr | 8 y | XR-MRI | Yes | OS | Cp | 4 y | No |
| Case 4 | 40 | M | R | PC | No | P-PA | Nr | 10 y | XR-MRI | No | AS | AV | 1 y | No |
Trau, previous trauma; CH, Cutaneous haemangioma; DeD, Delay in diagnosis; BA, Bone Affected; Treat, Type of treatment; F-up, Follow-up; Rec, Recurrence; y, years; F, Female; M, Male; R, Right; L, Left; SP, Suprapatellar; PC, Posterior compartment; Q, Quadriceps; P, Pain; PA, Pain with Activity, Tenderness H, Hemarthrosis; XR, radiography; Sc, Scintigraphy; MRI, Magnetic resonance image; MRIN, MRI negative; OS, Open surgery; C, Curettage; AN, Arthroscopy Negative; AS, Arthroscopic Surgery; Cp, Capillary; AV, Arteriovenous; Nr, not reported.
Knee synovial haemangioma literature review summary 2000–2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Our series 2020 | 4 | 20-22-31-40 y | 4 M | 4 R | SP (3) Q (1)- PC | No | P-PA-S-T-H | Nr | 7.2 y | XR-Sc-MRIN-MRI | Yes (3) | OS (3)-AS | AV (3)-Cp | 3.5 y (1 R) |
| Muramatsu et al. ( | 10 | 12.4 y (4 m−17 y) | 5 F-5 M | Nr | PFL (3)-PFM (2)-IP (1)-PC (2)-D (2) | yes | P-H-LRM | No | 2.5 y | XRP (1)-MRI | No | AB-OS | C (2)-Cp (6)-CCp (2) | 1 y |
| Tohma et al. ( | 1 | 41 y | M | R | MC | Nr | P-S- PTM-LRM | Nr | 30 y | XRB-MRI-MRA | Yes | OS | AV | 4 y |
| Goki-Kemei et al. ( | 1 | 38 y | F | R | MC | No | PA-S-T-E-LRM | Nr | Nr | MRI | No | AB-OS | SH | 3 m |
| Bawa et al. ( | 1 | 25 y | F | R | PFL | No | P-S-E-PTMF | No | 20 y | XR- MRI | No | AS | C | Nr |
| Beltrame et al. ( | 1 | 7 y | F | R | IP | Nr | P-S | Nr | Nr | MRGd | No | Nr | Nr | Nr |
| Begly et al. ( | 1 | 39 y | M | R | IN | Yes | P-L-LRM-T-E-H | No | 1 w | XR-MRI | No | AS | SH | Nr |
| Wen et al. ( | 1 | 14 m | F | R | IPL-IN | No | RW-Lu-PTM-H | Nr | 3 w | XRS-US-MRGd- | No | OS | C | Nr |
| Derzsi et al. ( | 1 | 13 y | M | L | PC | Yes | S-PTM-A-LRM | Nr | 2 y | XR-MRI | No | OS | AV | 21 m |
| Masquefa et al. ( | 1 | 37 y | F | Nr | PC | Nr | Nr | Nr | Nr | MRI | No | AS | SH | 22 m |
| Dunet et al. ( | Yes | P | No | 9 m | Rx-CT-MRGd | No | C | 5 y | ||||||
| Lopez-Oliva et al. ( | 4 | 22 y (6–43 y) | 2 F-2 M | Nr | IN-MC-SP-IP | Nr | P-S-A-LRM-H | Nr | 3 y | XRP (1)-XRO (3)-MRI | No | OS (3)-Ob | Nr (4) | 6.8 y |
| Arslan et al. ( | 1 | 23 y | M | L | SP-VMO | Nr | P-S-T | Nr | 1.5 y | XR-US-CT-MRGd | No | AB-Nr | SH | Nr |
| Guler et al. ( | 1 | 19 y | M | Nr | SP | Nr | P-S-T | Nr | Nr | XR-MRGd | No | Nr | Nr | Nr |
| Andrea Parra et al. ( | 1 | 2 y | M | R | SP-VL | Nr | P-S-M | Nr | 18 m | XRS-ED-MRI | No | OS | VVM | Nr |
| Mrani Alaoui et al. ( | 1 | 7 y | M | L | D | Yes | P-S-L-LRM-A | No | 12 m | XR-MRGd | Yes | OS | Cp | 36 m (R) |
| De Gori et al. ( | 1 | 67 y | M | L | D | Nr | P-S-Cl-Cr-T-LRM | Nr | 15 y | XRO-MRI | No | TKA | SH | 2 y |
| Kim et al. ( | 1 | 7 y | M | R | IP | Nr | S-H | Nr | 1 y | MRI-RBCSc-SPECT/CT | No | OS | V | Nr |
| Maeyama et al. ( | 1 | 15 y | F | R | MC | No | PA-S-A-LRM | Nr | 7 y | XRBO-Ar-CT-MRI | Yes | AS | SH | 5 y (SP) |
| Tahmasebi et al. ( | 1 | 45 y | F | R | PFM | No | PA-S-PTM-H | Nr | Nr | XR-MRI | No | AS | C | 1 y |
| Wong et al. ( | 1 | 5 y | M | R | IPM | No | P-S | Nr | 2 y | MRI | No | OS | SH | 32 m |
| Dalmonte et al. ( | 14 | 5 y (2.5–13 y) | 8 M-6 F | Nr | SIE-IIE-II (4 in two or more) | Nr | P-S-LRM-H | Yes (7) | 26 m | XRS (6)-XRP (2)-US-MRI | No | AB-OS | IAVM (14) | 46 m (2 R) (3 SP) |
| Hospach et al. ( | 1 | 15 y | M | R | SP-Q-B | Nr | P-S-LRM | Nr | 6 y | XR-US-ED-MRIN-MRGd | No | AN-AS | C | Nr |
| Lin et al. ( | 1 | 11 y | M | L | SP-IN | No | P-S-LRM-H | Yes | 1 y | XR-MDCTA | No | Cor-Bblo | Nr | 2 m |
| Sasho et al. ( | 2 | 37–60 y | F-M | R (2) | IP-SP | Nr | P-H | Nr | 19 y | XR-MRGd | No | AN-AS | C (2) | 2 y |
| Vakil-Adil et al. ( | 1 | 12 y | M | L | SP-VMO | Nr | P-S-PTM flexion | No | 3 y | XR-MRI | No | OS | C | Nr |
| Watanabe et al. ( | 1 | 3 y | F | L | IP | No | P-S-Li-E | No | 6 m | XRB-Sc-MRGd | Yes | AB-Ob | C | 6 m (R) (SP) |
| Holzapfel et al. ( | 1 | 29 y | M | L | MC | No | PA cross leg | No | 3 m | XRB-Sc-CT-MRGd | Yes | OS-C-BG | C | Nr |
| Ares-Rodriguez et al. ( | 1 | 10 m | M | L | IPM | Yes | P-Ed-Li-H | Nr | 24 h | Ar-MRI | No | OS | AV | 4 y |
| Rajni et al. ( | 1 | 10 y | F | R | No | D | Nr | 4 y | XRS-MRI | No | AB-OS | CCp | Nr | |
| Tzurbakis et al. ( | 1 | 34 y | M | R | IN | Yes | P-S-L-A | Nr | 5 y | XR-MRI | No | AS | Cp | 4 y |
| Barakat et al. ( | 1 | 24 y | F | L | PFM | No | P-H | Nr | 15 y | ED-MRI | No | AN-AS | C | 12 m |
| Carrol and Higgs ( | 1 | 10 y | M | R | SP | No | S-W-LRM-H | Nr | 8 y | XRC-US-MRI | Nr | Nr | Nr | Nr |
| Sanghi et al. ( | 1 | 7 y | F | L | SP | Yes | RW-LRM-PTM | Nr | 3 y | XR-ED-MRGd | No | AS | C | Nr |
| Silva et al. ( | 1 | 20 y | M | R | SP | No | P-S | Nr | 6 m | XR-MRI | No | AS | SH | 2 y |
| Yercan et al. ( | 3 | 11 y-21 y-22 y | 3 F | 2 R-l L | SP (3) VMO (1) | No | P-S-B-T-E-A-PTM-LRM-H | Nr | 6 y | XRS-CT-MRI | Yes (1) | AB-OS-C | CCp (1)-Nr (2) | 38 m |
| Zarza Pérez et al. ( | 1 | 37 y | F | R | IP | Nr | P-S-B-A-H | SA | 5 y | XR-MRI | No | AS | SH | 1 y |
| De Filippo et al. ( | 4 | 19–24 y | 3 F-1 M | Nr | IP (1)-Nr (3) | Nr | P-S-E | Nr | 6 y | XR-MRGd | No | AB-Nr | C (4) | Nr |
| Winzenberg et al. ( | 1 | 34 y | F | R | IN | Yes | P-Li-GW-L | Nr | 20 y | XR-MRIN | No | AS | Cp | 18 m |
| Coulier ( | 1 | 19 y | F | Nr | PC | Yes | P | Nr | 3 y | XR-CTArt-CTA-MRI | No | Ob | Nr | Nr |
| Okahashi et al. ( | 1 | 24 y | F | R | PFM | No | P-S-T-A | NR | 20 y | XR-MRI | No | AB-OS | Cp | 2 y |
| Ramseier et al. ( | 4 | 9-5-7-10 y | 2 F-2 M | 3 L-1 R | SPM-SPL-IPM-IP | Yes (1) | PW-LL-S-PTM | KT (2) | 3.9 y | XRO-XRP (1)-MRI | No | OS | SH (3)-C | 2.7 y (1 R) (4 SP) |
| Yilmaz et al. ( | 1 | 25 y | M | R | SP-Q | No | P-S-E-A | Yes | 10 y | XR-V-MRI | No | AB-Ob | VVM | 1 y |
| Akgün et al. ( | 4 | 19-22-13-35 y | 2 F-2 M | 4 R | 2 D-2 SP | Yes | P-S-B-E-H | Yes (2) | 4.5 y | XRO (1)-MRI | Yes (1) | AB-Ob (2) OS-AS | SH (3)-C | 2.6 y (2 SP) |
| Bonaga et al. ( | 4 | 4-18-20-49 y | 1 F-3 M | 3 L-1 R | D (4) | Nr | P-SL-LRM-H | SA (2)-KT (2) | Nr | XRO (1)-V-Ar-MRGd | No | AB-OS | AV (4) | 10 y (1 SP) |
| Del Notaro and Hug ( | 1 | 30 y | F | L | PC | Yes | PA-Li-E-LRM-H | Nr | 1 y | XR-MRI | No | ASF-OS | C | Nr |
| Neel et al. ( | 1 | 10 y | M | L | PC | Yes | P-L-E | No | 2 m | XR-MRGd | Yes | OS | SH | Nr |
| Suh et al. ( | 1 | 59 y | M | L | SPL | Nr | P-S-PTM-LRM | Nr | 40 y | XR-MRI | No | AB-OS | Cp | 6 m |
| Abe et al. ( | 3 | 5-12-16 y | 2 F-1 M | 2 R-1 L | SPL VL-SP-PF Q Gn | Nr | P-S-A-LRM-H | Nr | 8.3 y | XRP (2)-XRO (2)-MRI | No | AB-OS | C (2)-Cp | 7 y |
| Lassoued et al. ( | 1 | 25 y | M | R | D | No | P-H | No | 20 y | XRO-XRB-MRI | Yes | AN-OS | C | 4 y |
| Silit et al. ( | 1 | 39 y | M | R | MC | Nr | P-S-H | No | 10 m | XR-MRGd | Yes | ASI | CCp | 1 y |
| Aynaci et al. ( | 1 | 15 y | F | L | IPL | No | P-T-A | Nr | 6 m | XR-MRI | No | AS | VVM | 1 y |
| Total | 96 | Cases | Cases | Cases | Cases | Cases | Manuscript | Cases | Cases | Manuscript | Cases Yes 13 (13.5%) No 82 (85.4%) Nr 1 (1.0%) | Cases | Cases | Cases |
Trau, previous trauma; CH, Cutaneous haemangioma; DeD, Delay in diagnosis; BA, Bone affected; Treat, Type of treatment; F-up, Follow-up; m, Months; y, Years; w, Weeks; R, Recurrence; SP, Symptoms persisted; F, Female; M, Male; R, Right; L, Left; PFL, Patello-femoral lateral; PFM, Patello-femoral medial; IP, Infrapatellar (Hoffa fat pad); IPL, Infrapatellar Lateral; SP, Suprapatellar; SPL, Suprapatellar Lateral; MC, Medial Compartment; IN, Intercondylar Notch; PC, Posterior compartment; D, Diffuse; VMO, Vastus Medialis Obliquus; VL, Vastus Lateralis; Q, Quadriceps; Gn, Gastrocnemius; P, Pain; PA, Pain with Activity; Cl Claudication; Cr, Crepitus; RW, Patient Refused Weightbearing; L, Locking; Li, Limping; Lu, Lump; LL, Long Leg; SL, Short Leg; B, Buckling; GW, Giving Way; S, Swollen; T, Tenderness; W, Warmth; E, Effusion; A, Atrophy; PTM, Palpable tumor mass; PTMF, Palpable Tumor Mass more pronounced in Flexion; LRM, Limited Range of motion; H, Haemarthrosis; SA, Systemic Angiomatosis; KT, Klippel-Trénaunay; XR, radiography; XRS, XR Soft Tissue Mass; XRO, XR Osteoarthritis; XRB, XR Bone Involvement; XRP, XR Phleboliths; Ar, Arteriography; V, Venography; US, Ultrasound; ED, Echo Doppler; CT, Computed Tomography; CTArt, CT Arthrography; CTA, CT Angiography; MDCTA, Multi Detector Computed Tomography Angiography; Sc, Scintigraphy; RBCSc, Red blood cell scintigraphy; SPECT/CT, single-positron emission computed tomography-computed tomography; MRI, Magnetic resonance image; MRIN; MRI negative; MRA, MRI angiography; MRGd, MRI gadolinium enhancement; OS, Open surgery; C, Curettage; BG, Bone Graft; AN, Arthroscopy Negative; AB, Arthroscopic biopsy; AS, Arthroscopic Surgery; ASF, AS Failed. ASI, AS Incomplete; TKA, Total Knee Arthroplasty; Cor, Corticosteroid; Bblo, Beta blockers; C, Cavernous; Cp, Capillary; AV, Arteriovenous; CCp, Cavernous and capillary; SH, Synovial haemangioma; VVM, Venous Vascular Malformation; IAVN, Intraarticular Vascular Malformation; Nr, not reported; X ± SD: media ± standard deviation.
Figure 1Case 1: suprapatellar SH MRI. Conventional sagittal T1 (A) and T2 (B) MRI showing synovial haemangioma in the suprapatellar and supratrochlear synovial lining extending medially and eroding the supratrochlear cortical bone, with features of hyperintensity on T2-weighted imaging and hypo-/isointensity to muscles on T1. *Location of the Synovial Haemangioma tumor in the knee.
Figure 2Case 1: histology. Histological findings showing proliferation of arterial and venous vessels in a fibrous stromal tissue type (haematoxylin and eosin stain, 40×). The histological diagnosis was arteriovenous synovial haemangioma.
Figure 3Case 1: suprapatellar MRI tumor recurrence. MRI showing recurrence of the lesion. A heterogeneous hyperintense lesion is observed on sagittal T2-weighted imaging (B); it contains fibrous septa and is hypo-/isointense to muscles on the T1 sequence (A), with diffuse involvement of the sub-quadriceps synovial sac and tendon. *Location of the Synovial Haemangioma tumor in the knee.
Figure 4Case 2: suprapatellar SH MRI. Isointense T1 (A) and hyperintense T2 (B) sagittal MR images showing a synovial tumor just over the proximal pole of the patella with intra-osseous invasion of the upper pole of the patella. *Location of the Synovial Haemangioma tumor in the knee.
Figure 5Case 3: suprapatellar SH MRI. MR sagittal images showing an intra-articular synovial mass located superior and medial to the patella that eroded the superior patellar cortical bone; the mass was heterogeneously hypointense on T1-weighted imaging (A) and isointense on T2-weighted imaging (B). *Location of the Synovial Haemangioma tumor in the knee.
Figure 6Case 3: histology. Histological examination showing synovial proliferation and capillaries below, suggesting a capillary-type synovial haemangioma (haematoxylin and eosin stain, 40×).
Figure 7Case 4: posterior compartment SH MRI. Sagittal MRI sequences showing a well-defined intra-articular synovial mass in the posterior compartment of the knee, behind the PCL. On T1-weighted (A) sequences, the mass was isointense to the surrounding muscle with peripheral heterogeneous areas; the mass was hyperintense on T2-weighted images (B). *Location of the Synovial Haemangioma tumor in the knee.
Figure 8Case 4 posterior compartment SH arthroscopic view and puncture. (A). Arthroscopic view of the synovial haemangioma via the anterolateral portal, showing a pale bluish vascular lesion in the synovium lining the posterior capsule, just behind the PCL (1 × 0.5 × 0.5 cm). (B) Puncture of the synovial tumor produced acute bleeding that differentiated it from other tumors, such as LPVNS.
Figure 9Flow chart of information through the different phases of the systematic review.